Analystreport

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its "sell" rating re-affirmed by analysts at Zacks Investment Research.

Vanda Pharmaceuticals Inc.  (VNDA) 
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm Check Earnings Report